Börsiteade
AS PRFoods
LEI kood
529900PFXFO2ZDCRNK93
Emitendi suuruskategooria
Keskmise suurusega kontsern
Majandustegevusalad
Finants- ja kindlustustegevus
Emitendi registreeritud asukoht
Eesti
Üldandmed
Kategooriad
Juhtkonna vaheteadaanne või kvartaalne finantsaruanne
Teate ID
5358
Manused
Esitamise kuupäev ja aeg
18.02.2016 12:52:26
Teate sisu eesti keeles
Pealkiri
PRF: AS-i PRFoods 2015. aasta 4. kvartali ja 12 kuu konsolideeritud auditeerimata vahearuanne
Teade
Tallinn, Eesti, 2016-02-18 11:52 CET (GLOBE NEWSWIRE) --
Ülevaade majandustegevusest
JUHTKONNA KOMMENTAAR
PRFoods juhtkond on väga rahul 2015 tulemustega, me ületasime eelarvet nii
käibe kui kasumi osas, vaatamata meie põhiturgude, Soome ja Eesti
makromajanduslikele nõrkustele. Toorkala hinna volatiilsust tasakaalustasid
meie meeskonna töö tootmise ja müügitöö tõhustamisel. Ettevõtte
investeerimisprogramm viidi lõpule tähtaegselt ja eelarve piires. 2015 oli
ettevõttele esimene aasta tegutseda fokusseeritult kui kõrge lisandväärtusega
rahvusvaheline kalatöötlusettevõte ja majandustulemused kinnitavad, et ettevõte
on õigel kursil. PRFoods jätkab oma eesmärgi hoidmist, et olla oma sektoris üks
kasumlikumaid ettevõtteid ja klientide lemmik. PRFoods teatab dividendmakse
suuruse peale auditeeritud tulemuste avalikustamist.
AS PRFOODS AUDITEERIMATA MAJANDUSTULEMUSED, 4. KVARTAL 2015 VÕRRELDES 2014.
AASTA 4. KVARTALIGA
-- Auditeerimata konsolideeritud käive 17,2 miljonit eurot, kasv 19,7% ehk 2,8
miljonit eurot.
-- Brutomarginaal 14,9%, kasv 3,1 protsendipunkti.
-- Bioloogiliste varade ümberhindluse negatiivne mõju 0,4 miljonit eurot
(2014. aasta 4. kvartal: 0,3 miljonit eurot).
-- EBITDA äritegevusest 1,4 miljonit eurot, paranemine 1,7 miljoni euro võrra.
-- EBITDA 1,0 miljonit eurot, paranemine 1,7 miljonit eurot.
-- Ärikasum 0,7 miljonit eurot, paranemine 1,6 miljonit eurot.
-- Puhaskasum 0,7 miljonit eurot, paranemine 2,0 miljonit eurot.
AS PRFOODS AUDITEERIMATA MAJANDUSTULEMUSED, 12 KUUD 2015 VÕRRELDES 2014. AASTA
12 KUUGA
-- Auditeerimata konsolideeritud käive 50,3 miljonit eurot, kasv 9,6% ehk 4,4
miljonit eurot.
-- Brutomarginaal 13,4%, kasv 1,9 protsendipunkti.
-- Bioloogiliste varade ümberhindluse negatiivne mõju 0,9 miljonit eurot
(2014. aasta 12. kuud: 0,6 miljonit eurot).
-- EBITDA äritegevusest 2,9 miljonit eurot, paranemine 2,5 miljonit eurot.
-- EBITDA 2,0 miljonit eurot, paranemine 1,5 miljonit eurot*.
-- Ärikasum 0,9 miljonit eurot, paranemine 1,5 miljonit eurot.
-- Puhaskasum 1,2 miljonit eurot, paranemine 2,7 miljonit eurot.
* EBITDA, äri- ja puhaskasumi võrdlusandmetele avaldab negatiivset mõju 2014.
aasta juunis Rootsi Põllumajandusametilt saadud kahjunõue summas 751 tuhat
eurot, mis on kajastatud 2. kvartal 2014 kasumiaruandes real „Muud
äritulud/-kulud“.
VÕTMENÄITAJAD
Kasumi 1kv 2kv 3kv 4kv 12k 1kv 2kv 3kv 4kv
12k
aruann 2015 2015 2015 2015 2015 2014 2014 2014 2014
2014
e,
milj
EUR
--------------------------------------------------------------------------------
------
Müügit 10,3 11,4 11,4 17,2 50,3 10,2 11,3 10,0 14,3
45,9
ulu
--------------------------------------------------------------------------------
------
Brutok 1,3 1,3 1,6 2,6 6,8 1,4 1,0 1,2 1,7
5,3
asum
--------------------------------------------------------------------------------
------
EBITDA 0,4 0,4 0,7 1,4 2,9 0,5 -0,1 0,3 -0,3
0,4
ärite
gevuse
st
--------------------------------------------------------------------------------
------
EBITDA -0,6 0,6 1,1 1,0 2,0 -0,7 1,1 0,7 -0,7
0,5
--------------------------------------------------------------------------------
------
EBIT -0,9 0,3 0,8 0,7 0,9 -0,9 0,8 0,4 -0,9
-0,6
--------------------------------------------------------------------------------
------
EBT -0,8 0,3 0,8 0,7 1,1 -1,2 0,8 0,2 -1,2
-1,4
--------------------------------------------------------------------------------
------
Puhask -0,5 0,3 0,7 0,7 1,2 -0,9 0,6 0,1 -1,3
-1,5
asum
(-kah
jum)
--------------------------------------------------------------------------------
------
Brutor 12,2% 11,3% 14,5% 14,9% 13,4% 13,8% 8,6% 12,2% 11,8%
11,5%
entaab
lus
--------------------------------------------------------------------------------
------
Äriteg 4,1% 3,3% 6,5% 7,9% 5,8% 4,9% -1,1% 3,4% -2,4%
0,8%
evuse
EBITD
A
margi
naal
--------------------------------------------------------------------------------
------
EBITDA -5,9% 4,8% 9,4% 5,9% 4,0% -6,5% 10,0% 7,1% -4,6%
1,1%
margi
naal
--------------------------------------------------------------------------------
------
EBIT -8,6% 2,4% 6,8% 4,1% 1,7% -9,2% 7,5% 4,3% -6,6%
-1,3%
margi
naal
--------------------------------------------------------------------------------
------
EBT -7,4% 2,9% 6,6% 4,3% 2,1% -11,7% 7,0% 2,0% -8,2%
-3,0%
margi
naal
--------------------------------------------------------------------------------
------
Puhasr -5,2% 2,5% 6,1% 4,2% 2,3% -9,2% 5,2% 1,2% -8,9%
-3,3%
entaab
lus
--------------------------------------------------------------------------------
------
Tegevu 11,3% 11,3% 11,9% 9,3% 10,8% 12,6% 12,7% 13,2% 14,7%
13,4%
skulud
e
suhta
rv
--------------------------------------------------------------------------------
------
Bilans 31.03.2015 30.06.2015 30.09.2015 31.12.2015 31.03.2014 30.06.2014
30.09.2014 31.12.2014
s,
milj
EUR
--------------------------------------------------------------------------------
----------------------
Netovõ -3,3 -6,5 -5,2 -0,6 13,6 13,7
9,7 -2,6
lgnevu
s
--------------------------------------------------------------------------------
----------------------
Omakap 33,1 33,3 34,0 23,2 36,1 37,9
40,5 33,7
ital
--------------------------------------------------------------------------------
----------------------
Käibek 21,8 21,8 22,0 11,5 8,5 9,9
8,1 22,8
apital
--------------------------------------------------------------------------------
----------------------
Varad 39,5 39,4 40,1 29,5 63,8 68,5
65,6 40,4
--------------------------------------------------------------------------------
----------------------
Likvii 5,7 6,2 6,2 3,8 1,5 1,5
2,1 5,9
dsusko
rdaja
--------------------------------------------------------------------------------
----------------------
Omakap 83,9% 84,6% 84,7% 78,7% 56,5% 55,3%
61,6% 83,3%
itali
suhta
rv
--------------------------------------------------------------------------------
----------------------
Finant -11,0% -24,1% -18,2% -2,5% 27,4% 26,6%
19,3% -8,3%
svõime
ndus
--------------------------------------------------------------------------------
----------------------
Netovõ -11,2 -8,2 -4,4 -0,2 15,6 16,1
7,1 -7,0
lg/EBI
TDA
--------------------------------------------------------------------------------
----------------------
Omakap -3,2% -3,9% -2,3% 4,1% -3,6% 0,8%
0,3% -4,2%
itali
tootl
us
--------------------------------------------------------------------------------
----------------------
Varade -2,1% -2,6% -1,6% 3,4% -2,0% 0,4%
0,2% -2,9%
tootl
us
--------------------------------------------------------------------------------
----------------------
KONSOLIDEERITUD FINANTSSEISUNDI ARUANNE
EUR '000 31.12.2015 31.12.2014
----------------------------------------------------------
VARAD
----------------------------------------------------------
Raha ja ekvivalendid 1 921 3 330
----------------------------------------------------------
Nõuded ja ettemaksed 3 691 12 014
----------------------------------------------------------
Varud 5 616 6 563
----------------------------------------------------------
Bioloogilised varad 4 422 5 583
----------------------------------------------------------
Käibevara kokku 15 650 27 490
----------------------------------------------------------
----------------------------------------------------------
Edasilükkunud tulumaksuvara 137 103
----------------------------------------------------------
Pikaajalised finantsinvesteeringud 161 134
----------------------------------------------------------
Materiaalne põhivara 7 427 6 484
----------------------------------------------------------
Immateriaalne vara 6 128 6 218
----------------------------------------------------------
Põhivara kokku 13 853 12 939
----------------------------------------------------------
VARAD KOKKU 29 503 40 429
----------------------------------------------------------
----------------------------------------------------------
KOHUSTUSED JA OMAKAPITAL
----------------------------------------------------------
Võlakohustused 286 198
----------------------------------------------------------
Võlad ja ettemaksed 3 817 4 493
----------------------------------------------------------
Lühiajalised kohustused kokku 4 103 4 691
----------------------------------------------------------
----------------------------------------------------------
Võlakohustused 1 061 555
----------------------------------------------------------
Edasilükkunud tulumaksukohustus 244 457
----------------------------------------------------------
Sihtfinantseerimine 883 1 054
----------------------------------------------------------
Pikaajalised kohustused kokku 2 188 2 066
----------------------------------------------------------
KOHUSTUSED KOKKU 6 291 6 757
----------------------------------------------------------
----------------------------------------------------------
Aktsiakapital 7 737 19 342
----------------------------------------------------------
Ülekurss 16 026 16 026
----------------------------------------------------------
Oma aktsiad -172 -117
----------------------------------------------------------
Kohustuslik reservkapital 6 6
----------------------------------------------------------
Realiseerimata kursivahed 469 441
----------------------------------------------------------
Jaotamata kasum (-kahjum) -854 -2 026
----------------------------------------------------------
OMAKAPITAL KOKKU 23 212 33 672
----------------------------------------------------------
OMAKAPITAL JA KOHUSTUSED KOKKU 29 503 40 429
----------------------------------------------------------
KONSOLIDEERITUD KOONDKASUMIARUANNE
EUR '000 4kv 4kv 12k 12k
2015 2014 2015 2014
--------------------------------------------------------------------------------
Müügitulud 17 178 14 348 50 273 45 863
--------------------------------------------------------------------------------
Müüdud kaupade kulu -14 611 -12 661 -43 521 -40 581
--------------------------------------------------------------------------------
Brutokasum 2 567 1 687 6 752 5 282
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Tegevuskulud -1 606 -2 107 -5 418 -6 153
--------------------------------------------------------------------------------
Turundus- ja müügikulud -1 228 -912 -4 012 -3 598
--------------------------------------------------------------------------------
Üldhalduskulud -378 -1 195 -1 406 -2 555
--------------------------------------------------------------------------------
Muud äritulud/-kulud 96 -201 406 831
--------------------------------------------------------------------------------
Bioloogiliste varade ümberhindlus -359 -323 -888 -571
--------------------------------------------------------------------------------
Ärikasum (-kahjum) 698 -944 852 -611
--------------------------------------------------------------------------------
Finantstulud 65 75 303 87
--------------------------------------------------------------------------------
Finantskulud -23 -305 -103 -844
--------------------------------------------------------------------------------
Maksustamiseelne kasum (-kahjum) 740 -1 174 1 052 -1 368
--------------------------------------------------------------------------------
Tulumaks -10 -106 120 -136
--------------------------------------------------------------------------------
Jätkuvate tegevusvaldkondade aruandeperioodi 730 -1 280 1 172 -1 504
puhaskasum (-kahjum)
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Lõpetatud tegevusvaldkondade aruandeperioodi 0 -5 206 0 -1 310
puhaskahjum
--------------------------------------------------------------------------------
Puhaskasum (-kahjum) 730 -6 486 1 172 -2 814
--------------------------------------------------------------------------------
Muu koondkasum (-kahjum), mis on hiljem
võimalik ümber klassifitseerida
kasumiaruandesse:
--------------------------------------------------------------------------------
Valuutakursi vahed 30 -256 28 -308
--------------------------------------------------------------------------------
sealhulgas jätkuvad tegevusvaldkonnad 30 -33 28 -98
--------------------------------------------------------------------------------
sealhulgas lõpetatud tegevusvaldkonnad 0 -223 0 -210
--------------------------------------------------------------------------------
Kokku koondkasum (-kahjum) 760 -6 742 1 200 -3 122
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Tava puhaskasum (-kahjum) aktsia kohta (€) 0,02 -0,17 0,03 -0,07
--------------------------------------------------------------------------------
sealhulgas jätkuvad tegevusvaldkonnad 0,02 -0,03 0,03 -0,04
--------------------------------------------------------------------------------
sealhulgas lõpetatud tegevusvaldkonnad 0,00 -0,13 0,00 -0,03
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Lahustatud puhaskasum (-kahjum) aktsia kohta 0,02 -0,17 0,03 -0,07
(€)
--------------------------------------------------------------------------------
sealhulgas jätkuvad tegevusvaldkonnad 0,02 -0,03 0,03 -0,04
--------------------------------------------------------------------------------
sealhulgas lõpetatud tegevusvaldkonnad 0,00 -0,13 0,00 -0,03
--------------------------------------------------------------------------------
Indrek Kasela
AS PRFoods
Juhatuse liige
T: +372 6033 800
[email protected]
www.prfoods.ee
Teate sisu inglise keeles
Pealkiri
PRF: Consolidated Unaudited Interim Report of AS PRFoods for 4th quarter and 12 months of 2015
Teade
Tallinn, Estonia, 2016-02-18 11:52 CET (GLOBE NEWSWIRE) --
Overview of the Economic Activities
MANAGEMENT COMMENTARY
PRFoods management is very pleased with the results of 2015, we exceeded the
budget both on sales and profitability despite challenging macro environment in
our key markets of Finland and Estonia. Volatility in raw fish prices was
counterbalanced by impressive production efficiency and sales efforts by our
team. The company implemented its investment program on time and on budget.
2015 was first full year for the company as dedicated value added fish
processing company and the results prove that company is on right track.
PRFoods will maintain its target to be one of the most profitable companies in
the sector and favourite for the customers. PRFoods will announce the dividend
amount once the audit for 2015 is completed.
UNAUDITED FINANCIAL RESULTS OF AS PRFOODS, THE 4TH QUARTER OF 2015 COMPARED TO
THE 4THQUARTER OF 2014
-- Unaudited consolidated revenue 17.2 million euros, increase 19.7%, i.e. 2.8
million euros.
-- Gross margin 14.9%, increase 3.1 percentage points.
-- The negative effect of revaluation of biological assets 0.4 million euros
(Q4 2014: 0.3 million euros).
-- EBITDA from business operations 1.4 million euros, increase 1.7 million
euros.
-- EBITDA 1.0 million euros, increase 1.7 million euros.
-- EBIT 0.7 million euros, increase 1.6 million euros.
-- Net profit 0.7 million euros, increase 2.0 million euros.
UNAUDITED FINANCIAL RESULTS OF AS PRFOODS, 12 MONTHS OF 2015 COMPARED TO 12
MONTHS OF 2014
-- Unaudited consolidated revenue 50.3 million euros, increase 9.6%, i.e. 4.4
million euros.
-- Gross margin 13.4%, increase 1.9 percentage points.
-- The negative effect of revaluation of biological assets 0.9 million euros
(12 months 2014: 0.6 million euros).
-- EBITDA from business operations 2.9 million euros, increase 2.5 million
euros.
-- EBITDA 2.0 million euros, increase 1.5 million euros*.
-- EBIT 0.9 million euros, increase 1.5 million euros.
-- Net profit 1.2 million euros, increase 2.7 million euros.
* Negative effect in comparing data of EBITDA, EBIT and net profit is caused by
the reimbursement of a claim in the amount of 751 thousand euros received in
June 2014 from the Swedish Board of Agriculture, recorded in the income
statement of Q2 2014 on line “Other business incomes/costs”.
KEY RATIOS
Profit Q1 Q2 Q3 Q4 12m 15 Q1 Q2 Q3 Q4
12m 14
& 2015 2015 2015 2015 2014 2014 2014 2014
Loss,
EUR
mln
--------------------------------------------------------------------------------
------
Sales 10.3 11.4 11.4 17.2 50.3 10.2 11.3 10.0 14.3
45.9
--------------------------------------------------------------------------------
------
Gross 1.3 1.3 1.6 2.6 6.8 1.4 1.0 1.2 1.7
5.3
profi
t
--------------------------------------------------------------------------------
------
EBITDA 0.4 0.4 0.7 1.4 2.9 0.5 -0.1 0.3 -0.3
0.4
from
opera
tions
--------------------------------------------------------------------------------
------
EBITDA -0.6 0.6 1.1 1.0 2.0 -0.7 1.1 0.7 -0.7
0.5
--------------------------------------------------------------------------------
------
EBIT -0.9 0.3 0.8 0.7 0.9 -0.9 0.8 0.4 -0.9
-0.6
--------------------------------------------------------------------------------
------
EBT -0.8 0.3 0.8 0.7 1.1 -1.2 0.8 0.2 -1.2
-1.4
--------------------------------------------------------------------------------
------
Net -0.5 0.3 0.7 0.7 1.2 -0.9 0.6 0.1 -1.3
-1.5
profi
t
(-los
s)
--------------------------------------------------------------------------------
------
Gross 12.2% 11.3% 14.5% 14.9% 13.4% 13.8% 8.6% 12.2% 11.8%
11.5%
margi
n
--------------------------------------------------------------------------------
------
Operat 4.1% 3.3% 6.5% 7.9% 5.8% 4.9% -1.1% 3.4% -2.4%
0.8%
ional
EBITD
A
margi
n
--------------------------------------------------------------------------------
------
EBITDA -5.9% 4.8% 9.4% 5.9% 4.0% -6.5% 10.0% 7.1% -4.6%
1.1%
margi
n
--------------------------------------------------------------------------------
------
EBIT -8.6% 2.4% 6.8% 4.1% 1.7% -9.2% 7.5% 4.3% -6.6%
-1.3%
margi
n
--------------------------------------------------------------------------------
------
EBT -7.4% 2.9% 6.6% 4.3% 2.1% -11.7% 7.0% 2.0% -8.2%
-3.0%
margi
n
--------------------------------------------------------------------------------
------
Net -5.2% 2.5% 6.1% 4.2% 2.3% -9.2% 5.2% 1.2% -8.9%
-3.3%
margi
n
--------------------------------------------------------------------------------
------
Operat 11.3% 11.3% 11.9% 9.3% 10.8% 12.6% 12.7% 13.2% 14.7%
13.4%
ing
expen
se
ratio
--------------------------------------------------------------------------------
------
Balance 31/03/2 30/06/2 30/09/2 31/12/2 31/03/ 30/06/ 30/09/ 31/12/
Sheet, EUR 015 015 015 015 2014 2014 2014 2014
mln
--------------------------------------------------------------------------------
Net debt -3.3 -6.5 -5.2 -0.6 13.6 13.7 9.7 -2.6
--------------------------------------------------------------------------------
Equity 33.1 33.3 34.0 23.2 36.1 37.9 40.5 33.7
--------------------------------------------------------------------------------
Working 21.8 21.8 22.0 11.5 8.5 9.9 8.1 22.8
capital
--------------------------------------------------------------------------------
Assets 39.5 39.4 40.1 29.5 63.8 68.5 65.6 40.4
--------------------------------------------------------------------------------
Liquidity 5.7 6.2 6.2 3.8 1.5 1.5 2.1 5.9
ratio
--------------------------------------------------------------------------------
Equity ratio 83.9% 84.6% 84.7% 78.7% 56.5% 55.3% 61.6% 83.3%
--------------------------------------------------------------------------------
Gearing -11.0% -24.1% -18.2% -2.5% 27.4% 26.6% 19.3% -8.3%
ratio
--------------------------------------------------------------------------------
Net -11.2 -8.2 -4.4 -0.2 15.6 16.1 7.1 -7.0
debt-to-EBI
TDA
--------------------------------------------------------------------------------
ROE -3.2% -3.9% -2.3% 4.1% -3.6% 0.8% 0.3% -4.2%
--------------------------------------------------------------------------------
ROA -2.1% -2.6% -1.6% 3.4% -2.0% 0.4% 0.2% -2.9%
--------------------------------------------------------------------------------
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
EUR '000 31/12/2015 31/12/2014
-------------------------------------------------------
ASSETS
-------------------------------------------------------
Cash and cash equivalents 1,921 3,330
-------------------------------------------------------
Receivables and prepayments 3,691 12,014
-------------------------------------------------------
Inventories 5,616 6,563
-------------------------------------------------------
Biological assets 4,422 5,583
-------------------------------------------------------
Total current assets 15,650 27,490
-------------------------------------------------------
-------------------------------------------------------
Deferred income tax 137 103
-------------------------------------------------------
Long-term financial investments 161 134
-------------------------------------------------------
Tangible fixed assets 7,427 6,484
-------------------------------------------------------
Intangible assets 6,128 6,218
-------------------------------------------------------
Total non-current assets 13,853 12,939
-------------------------------------------------------
TOTAL ASSETS 29,503 40,429
-------------------------------------------------------
-------------------------------------------------------
EQUITY AND LIABILITIES
-------------------------------------------------------
Loans and borrowings 286 198
-------------------------------------------------------
Payables 3,817 4,493
-------------------------------------------------------
Total current liabilities 4,103 4,691
-------------------------------------------------------
-------------------------------------------------------
Loans and borrowings 1,061 555
-------------------------------------------------------
Deferred tax liabilities 244 457
-------------------------------------------------------
Government grants 883 1,054
-------------------------------------------------------
Total non-current liabilities 2,188 2,066
-------------------------------------------------------
TOTAL LIABILITIES 6,291 6,757
-------------------------------------------------------
-------------------------------------------------------
Share capital 7,737 19,342
-------------------------------------------------------
Share premium 16,026 16,026
-------------------------------------------------------
Treasury shares -172 -117
-------------------------------------------------------
Statutory capital reserve 6 6
-------------------------------------------------------
Currency translation reserve 469 441
-------------------------------------------------------
Retained profit (-loss) -854 -2,026
-------------------------------------------------------
TOTAL EQUITY 23,212 33,672
-------------------------------------------------------
TOTAL EQUITY AND LIABILITIES 29,503 40,429
-------------------------------------------------------
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
EUR '000 Q4 2015 Q4 2014 12m 12m
2015 2014
--------------------------------------------------------------------------------
Sales 17,178 14,348 50,273 45,863
--------------------------------------------------------------------------------
Cost of goods sold -14,611 -12,661 -43,521 -40,581
--------------------------------------------------------------------------------
Gross profit 2,567 1,687 6,752 5,282
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Operating expenses -1,606 -2,107 -5,418 -6,153
--------------------------------------------------------------------------------
Selling and distribution expenses -1,228 -912 -4,012 -3,598
--------------------------------------------------------------------------------
Administrative expenses -378 -1,195 -1,406 -2,555
--------------------------------------------------------------------------------
Other income/expenses 96 -201 406 831
--------------------------------------------------------------------------------
Fair value adjustment on biological assets -359 -323 -888 -571
--------------------------------------------------------------------------------
Operating profit (-loss) 698 -944 852 -611
--------------------------------------------------------------------------------
Financial income 65 75 303 87
--------------------------------------------------------------------------------
Financial expenses -23 -305 -103 -844
--------------------------------------------------------------------------------
Profit (-loss) before tax 740 -1,174 1,052 -1,368
--------------------------------------------------------------------------------
Income tax -10 -106 120 -136
--------------------------------------------------------------------------------
Net profit (-loss) for the year from 730 -1,280 1,172 -1,504
continuing operations
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Net loss for the year from discontinuing 0 -5,206 0 -1,310
operations (attributable to equity holders
of the company)
--------------------------------------------------------------------------------
Net profit (loss) 730 -6,486 1,172 -2,814
--------------------------------------------------------------------------------
Other comprehensive income (-expense) that
might subsequently classified to profit or
loss:
--------------------------------------------------------------------------------
Foreign currency translation differences 30 -256 28 -308
--------------------------------------------------------------------------------
including continued operations 30 -33 28 -98
--------------------------------------------------------------------------------
including discontinued operations 0 -223 0 -210
--------------------------------------------------------------------------------
Total comprehensive income (-expense) 760 -6,742 1,200 -3,122
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Profit (-loss) per share (€) 0.02 -0.17 0.03 -0.07
--------------------------------------------------------------------------------
including continued operations 0.02 -0.03 0.03 -0.04
--------------------------------------------------------------------------------
including discontinued operations 0.00 -0.13 0.00 -0.03
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Diluted profit (-loss) per share (€) 0.02 -0.17 0.03 -0.07
--------------------------------------------------------------------------------
including continued operations 0.02 -0.03 0.03 -0.04
--------------------------------------------------------------------------------
including discontinued operations 0.00 -0.13 0.00 -0.03
--------------------------------------------------------------------------------
Indrek Kasela
AS PRFoods
Member of the Management Board
Phone: +372 6033 800
[email protected]
www.prfoods.ee